CareLit · DOI-Nachweis · Diabetologie und Stoffwechsel
New insulin glargine 300 U/mL: Glycemic control and hypoglycemia in a meta-analysis of EDITION clinical trials in people with T2DM
DOI 10.1055/s-0035-1549622
Bibliografische Angaben
Nachweis in CareLit
Autor:innenR Ritzel, R Roussel, GB Bolli, L Vinet, H Yki-Järvinen
ZeitschriftDiabetologie und Stoffwechsel
Ausgabe04/2015
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Background and aims: The EDITION 1, 2 and 3 studies compared the efficacy and safety of new insulin glargine 300 U/mL (Gla-300) with insulin glargine 100 U/mL (Gla-100) in people with type 2 diabetes mellitus on basal and mealtime insulin, basal insulin and OADs, and no prior insulin, respectively. A meta-analysis of these studies was conducted to study efficacy and safety. Materials and methods: Meta-analysis of th…
Zitieren
Zitierempfehlung
R Ritzel, R Roussel, GB Bolli, L Vinet, H Yki-Järvinen (2015) New insulin glargine 300 U/mL: Glycemic control and hypoglycemia in a meta-analysis of EDITION clinical trials in people with T2DM. Diabetologie und Stoffwechsel (04). https://doi.org/10.1055/s-0035-1549622
Mit CareLit weiterarbeiten